CTSG is also closely related to the survival of several cancer types, including soft tissue sarcoma, muscular invasive bladder cancer, and lymph node-negative breast cancer (39), and is a potential immune-related biomarker for OSCC (40). Here, CTSG is linked to soft tissue sarcoma.